SARAH WELCH: Open Payments
NPI 1326178476 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,505 in 103 payments from 11 companies in 2025. Trend: 2023 $1,063 · 2024 $1,015 · 2025 $2,505
Food & beverage: $2,505
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 21 | $510 |
| Vanda Pharmaceuticals Inc. | 13 | $452 |
| Alkermes, Inc. | 13 | $304 |
| E.R. Squibb & Sons, L.L.C. | 10 | $234 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $206 |
| Teva Pharmaceuticals USA, Inc. | 8 | $199 |
| Neurocrine BioSciences, Inc. | 9 | $192 |
| Axsome Therapeutics, Inc. | 4 | $191 |
| ABBVIE INC. | 9 | $136 |
| Lundbeck LLC | 3 | $61 |
Products named: REXULTI, FANAPT, COBENFY, CAPLYTA, UZEDY, INGREZZA, Auvelity, LYBALVI.
Industry payments across TN — which companies pay providers there.
